Malaga Cove Capital’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$858K Sell
9,489
-413
-4% -$34.6K 0.27% 92
2026
Q1
$793K Buy
9,902
+808
+9% +$66.6K 0.28% 92
2025
Q4
$775K Sell
9,094
-1,478
-14% -$121K 0.27% 100
2025
Q3
$822K Buy
10,572
+593
+6% +$46.3K 0.3% 96
2025
Q2
$780K Sell
9,979
-169
-2% -$12.6K 0.31% 88
2025
Q1
$736K Sell
10,148
-28
-0.3% -$2K 0.32% 91
2024
Q4
$753K Buy
10,176
+339
+3% +$23.7K 0.3% 87
2024
Q3
$649K Buy
9,837
+2,934
+43% +$213K 0.26% 97
2024
Q2
$638K Hold
6,903
0.26% 101
2024
Q1
$660K Sell
6,903
-4
-0.1% -$336 0.27% 99
2023
Q4
$527K Buy
6,907
+2,076
+43% +$144K 0.22% 112
2023
Q3
$335K Buy
4,831
+2,320
+92% +$186K 0.15% 136
2023
Q2
$237K Sell
2,511
-6
-0.2% -$521 0.11% 144
2023
Q1
$208K Buy
+2,517
New +$198K 0.1% 147
2015
Q2
Sell
-24,798
Closed -$577K 109
2015
Q1
$577K Sell
24,798
-60
-0.2% -$1.35K 0.46% 57
2014
Q4
$536K Buy
+24,858
New +$499K 0.43% 58

Other funds holding EW

Malaga Cove Capital's EW Position: Q2 2026 in Review

Malaga Cove Capital reduced its Edwards Lifesciences (EW) stake by 4.2% in Q2 2026, selling an estimated $34.6K and leaving 9,489 shares worth $858K. The position accounts for 0.27% of the portfolio, ranked #92.

Malaga Cove Capital first reported a position in EW in Q4 2014 and has held it in 16 quarters since. 1,328 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Malaga Cove Capital held 9,489 shares of Edwards Lifesciences worth $858K as of Q2 2026.
  • Malaga Cove Capital sold 413 Edwards Lifesciences shares in Q2 2026, an estimated $34.6K.
  • Edwards Lifesciences made up 0.27% of Malaga Cove Capital's portfolio in Q2 2026, its #92 holding.
  • Malaga Cove Capital first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 16 quarters since.
  • 1,328 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Malaga Cove Capital's 13F filing for Q2 2026, filed 24 Jul 2026.